PATENT LAW IN BIOTECHNOLOGY CHEMICALS - GBV

fettlepluckyBiotechnology

Dec 1, 2012 (4 years and 11 months ago)

220 views

Z1* i V
PATEN T LA W
IN BIOTECHNOLOG Y
CHEMICAL S &
PHARMACEUTICAL S
SECOND EDITION
HAROLD C WEGNER
STOCKTO N
SUMMARY
Preface to the Second Edition ix
Preface to the First Edition xiii
Recent Trends and Imminent Changes xvi
Detailed Table of Contents xxiii
OVERVIEW 1
TRADE SECRETS 12
PATENT OVERVIEW 3 8
Inventorship Requirements (§§ 116-118) 46
The Paris Convention (and Other Treaties) 82
Patent Procurement Strategies 104
PATENT-ELIGIBLE SUBJECT MATTER 123
NOVELTY (ANTICIPATION) 133
OBVIOUSNESS 21 9
Homologs, Isomers and Analogs 278
Proving a Difference in Properties 285
Method of Making or Using Obviousness 301
Method of Making Obviousness Issues 330
Product-by-process Claims 351
Purity and Activity Level Limitations 391
Jepson and Other Prior Art "Admissions" 394
CLAIMS AND THEIR INTERPRETATION 397
Claim Structure 40 5
"Means" Limitations 42 2
Determining the Literal Scope of the Claim 427
INFRINGING ACTS 44 7
Infringement Determination 514
The Doctrine of Equivalents 526
File Wrapper (Prosecution History) Estoppel 568
Reverse Doctrine of Equivalents 578
DISCLOSURE REQUIREMENTS 586
Written Description Requirement \ 597
Enablement, "How to Make" 620
How to Use 64 5
The "Best Mode Contemplated * * *" 794
Biotechnology Deposits 81 7
DUTY OF DISCLOSURE 857
DOUBLE PATENTING 898
Restriction Practice 91 8
Election of Species 92 8
Markush-Election Interface . 930
INTERNATIONAL UNITY STANDARDS 953
International Practice Differences 957
PLANT VARIETY PROTECTION ACT ("PVPA") 964
TABLE OF CASES 977
INDEX 1007
VII